104
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Antinuclear antibody prevalence in a general pediatric cohort from Mexico City: discordance between immunofluorescence and multiplex assays

, , , , , , & show all
Pages 1-8 | Published online: 20 Dec 2016

Figures & data

Figure 1 Representative photomicrographs of antinuclear antibody (ANA) patterns at 400× magnification. (A) negative ANA; (B) positive/homogeneous pattern; (C) positive/speckled pattern; (D) positive/nucleolar pattern.

Figure 1 Representative photomicrographs of antinuclear antibody (ANA) patterns at 400× magnification. (A) negative ANA; (B) positive/homogeneous pattern; (C) positive/speckled pattern; (D) positive/nucleolar pattern.

Figure 2 (A) ANA titers and patterns, by indirect IFA. (B) Autoantibody specificities by multiplex-11 assay. Four specificities did not yield any positives (ribosomal P, SS-A, centromere B, and Jo-1).

Abbreviations: ANA, antinuclear antibody; dsDNA, double-stranded DNA; IFA, immunofluorescence assay.
Figure 2 (A) ANA titers and patterns, by indirect IFA. (B) Autoantibody specificities by multiplex-11 assay. Four specificities did not yield any positives (ribosomal P, SS-A, centromere B, and Jo-1).

Table 1 ANA positivity according to assay method in a pediatric cohort (aged 9–17 years) from Mexico City

Figure 3 Age distributions according to ANA screening status by indirect IFA and multiplex-11 assays.

Abbreviations: ANA, antinuclear antibody; IFA, immunofluorescence assay.
Figure 3 Age distributions according to ANA screening status by indirect IFA and multiplex-11 assays.

Figure 4 Proportional Venn diagram displaying overlap in positivity for ANA assay methods (n=114). Corresponding sensitivity, specificity, and kappa estimates are presented, for multiplex compared to IFA (≥1:80) as the “gold standard”. Multiplex-10 excludes the dsDNA antigen from the full multiplex-11 panel.

Abbreviations: ANA, antinuclear antibody; dsDNA, double-stranded DNA; IFA, immunofluorescence assay.
Figure 4 Proportional Venn diagram displaying overlap in positivity for ANA assay methods (n=114). Corresponding sensitivity, specificity, and kappa estimates are presented, for multiplex compared to IFA (≥1:80) as the “gold standard”. Multiplex-10 excludes the dsDNA antigen from the full multiplex-11 panel.

Table 2 Comparison of IFA titers and number of multiplex-positive antigens